3D Printed Drugs Market by Technique Type and By Region – Global Opportunities & Forecast, 2020-2027
3D Printed Drugs Market by Technique Type (Fused Deposition Modelling, Inkjet Printing, Selective Laser Sintering, Stereolithography and Others) and By Region – Global Opportunities & Forecast, 2020-2027
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global 3D Printed Drugs Market- Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global 3D Printed Drugs Market Revenue Forecast till 2027
5. Global 3D Printed Drugs Market by Technique Type Revenue Forecast till 2027
5.1. Fused Deposition Modelling
5.2. Inkjet Printing Infant
5.3. Selective Laser Sintering
5.4. Stereolithography
5.5. Others
6. Global 3D Printed Drugs Market by Region Forecast till 2027
6.1. North America 3D Printed Drugs Market Revenue Forecast till 2027
(Option 1: As a part of the free 25% customization)
6.1.1. North America 3D Printed Drugs Market by Technique Type
6.1.1.1. Fused Deposition Modelling
6.1.1.2. Inkjet Printing Infant
6.1.1.3. Selective Laser Sintering
6.1.1.4. Stereolithography
6.1.1.5. Others
6.1.2. US 3D Printed Drugs Market All-Up
6.1.3. Canada 3D Printed Drugs Market All-Up
6.2. Europe 3D Printed Drugs Market Revenue Forecast till 2027
(Option 2: As a part of the free 25% customization)
6.2.1. Europe 3D Printed Drugs Market by Technique Type
6.2.1.1. Fused Deposition Modelling
6.2.1.2. Inkjet Printing Infant
6.2.1.3. Selective Laser Sintering
6.2.1.4. Stereolithography
6.2.1.5. Others
6.2.2. UK 3D Printed Drugs Market All-Up
6.2.3. Germany 3D Printed Drugs Market All-Up
6.2.4. France 3D Printed Drugs Market All-Up
6.2.5. Spain 3D Printed Drugs Market All-Up
6.2.6. Rest of Europe 3D Printed Drugs Market All-Up
6.3. Asia-Pacific 3D Printed Drugs Market Revenue Forecast till 2027
(Option 3: As a part of the free 25% customization)
6.3.1. Asia-Pacific 3D Printed Drugs Market by Technique Type
6.3.1.1. Fused Deposition Modelling
6.3.1.2. Inkjet Printing Infant
6.3.1.3. Selective Laser Sintering
6.3.1.4. Stereolithography
6.3.1.5. Others
6.3.2. China 3D Printed Drugs Market All-Up
6.3.3. India 3D Printed Drugs Market All-Up
6.3.4. Japan 3D Printed Drugs Market All-Up
6.3.5. Rest of APAC 3D Printed Drugs Market All-Up
6.4. RoW 3D Printed Drugs Market Revenue Forecast till 2027
(Option 4: As a part of the free 25% customization)
6.4.1. RoW 3D Printed Drugs Market by Technique Type
6.4.1.1. Fused Deposition Modelling
6.4.1.2. Inkjet Printing Infant
6.4.1.3. Selective Laser Sintering
6.4.1.4. Stereolithography
6.4.1.5. Others
6.4.2. Brazil 3D Printed Drugs Market All-Up
6.4.3. South Africa 3D Printed Drugs Market All-Up
6.4.4. Saudi Arabia 3D Printed Drugs Market All-Up
6.4.5. UAE 3D Printed Drugs Market All-Up
6.4.6. Rest of world (remaining countries of the LAMEA region) 3D Printed Drugs Market All-Up
7. Competitive Landscape Analysis
7.1. Porter’s Five Forces Analysis
7.2. Industry – Competitive Landscape
7.3. Market Presence (Intensity Mapping)
7.4. Key Strategic Market Developments
8. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
8.1. Aprecia Pharmaceuticals LLC
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Footprint & Employee Strength
8.1.4. Product Offerings
8.1.5. Financials
8.1.6. Key Company Developments
8.2. GlaxoSmithKline Plc.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Footprint & Employee Strength
8.2.4. Product Offerings
8.2.5. Financials
8.2.6. Key Company Developments
8.3. FabRx Ltd.
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Footprint & Employee Strength
8.3.4. Product Offerings
8.3.5. Financials
8.3.6. Key Company Developments
8.4. Hewlett Packard Caribe
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Footprint & Employee Strength
8.4.4. Product Offerings
8.4.5. Financials
8.4.6. Key Company Developments
8.5. Merck KGaA
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Footprint & Employee Strength
8.5.4. Product Offerings
8.5.5. Financials
8.5.6. Key Company Developments
8.6. Cycle Pharmaceuticals
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Footprint & Employee Strength
8.6.4. Product Offerings
8.6.5. Financials
8.6.6. Key Company Developments
8.7. Tvasta
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Footprint & Employee Strength
8.7.4. Product Offerings
8.7.5. Financials
8.7.6. Key Company Developments
9. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
- Published Date: Feb - 2021
- Report Format: Excel/PPT
- Report Code: HM14A-00-0918
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
3D Printed Drugs Market by Technique Type and By Region – Global Opportunities & Forecast, 2020-2027
$ 4,499.00 – $ 6,649.00
Why GMI Research
